References
- McLeod BC. Apheresis: principles and practice. Bethesda: AAABB Press; 2003.
- Stegmayr BG. A survey of blood purification techniques. Transfus Apher Sci. 2005;32:209–20.
- Tan HK, Hart G. Plasma filtration. Ann Acad Med Singapore. 2005;34:615–24.
- Ullrich H, Kuehnl P. New trends in specific immunoadsorption. Transfus Apher Sci. 2004;30:223–31.
- Stegmayr B, Wikhdal AM. Access in therapeutic apheresis. Ther Apher Dial. 2003;7:209–14.
- Szczepiorkowski ZM, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R. Guidelines on the use of therapeutic apheresis in clinical practice - Evidence-based approach from the apheresis applications committee of the American society for apheresis. J Clin Apher. 2007;22:106–75.
- Schwartz J, Winters JL, Padmanabhan A, Balogun RA, Delaney M, Linenberger ML, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. J Clin Apher. 2013;28:145–284.
- McLeod BC. Therapeutic apheresis: use of human serum albumin, fresh frozen plasma and cryusupernatant plasma in therapeutic plasma exchange. Best Pract Res Clin Haematol. 2006;19:157–67.
- McLeod BC. Plasma and plasma derivates in therapeutic plasmapheresis. Transfusion. 2012;52(Suppl 1):38S–44S.
- Shemin D, Briggs D, Greenan M. Complications of therapeutic plasma exchange: a prospective study of 1,727 procedures. J Clin Apher. 2007;22:270–6.
- Tomita T, Takayanagi M, Kiwada K, Mieda A, Takahashi C, Hata T. Vasovagal reactions in apheresis donors. Transfusion. 2002;42:1561–6.
- Galacki DM. An overview of therapeutic apheresis in pediatrics. J Clin Apher. 1997;12:1–3.
- Norda R, Berséus O, Stegmayr B. Adverse events and problems in therapeutic hemapheresis. A report from the Swedish registry. Transfus Apher Sci. 2001;25:33–41.
- Weinstein R. Hypocalcemic toxicity and atypical reactions in therapeutic plasma exchange. J Clin Apher. 2001;16:210–1.
- Marques MB, Huang ST. Patients with thrombotic thrombocytopenic purpura commonly develop metabolic alkalosis during therapeutic plasma exchange. J Clin Apher. 2001;16:120–4.
- Arepally GM, Ortel TL. Heparin-induced thrombocytopenia. Annu Rev Med. 2010;61:77–90.
- Ibrahim RB, Liu C, Cronin SM, Murphy BC, Cha R, Swerdlow P, et al. Drug removal by plasmapheresis: an evidence-based review. Pharmacotherapy. 2007;27:1529–49.
- McLeod BC. Therapeutic apheresis: history, clinical application, and lingering uncertainties. Transfusion. 2009,50:1413–26.
- Norda R, Stegmayr BG, The Swedish Apheresis Group. Therapeutic apheresis in Sweden: update of epidemiology and adverse events. Transfus Apher Sci. 2003;29:159–66.
- Mokrzycki MH, Kaplan AA. Therapeutic plasma exchange: complications and management. Am J Kidney Dis. 1994;23:817–27.
- Basic-Jukic N, Kes P, Glavas-Boras S, Brunetta B, Bubic-Filipi L, Puretic Z. Complications of therapeutic plasma exchange: experience with 4857 treatments. Ther Apher Dial. 2005;9:391–5.
- Michon B, Moghrabi A, Winikoff R, Barrette S, Bernstein ML, Champagne J, et al. Complications of apheresis in children. Transfusion. 2007;47:1837–42.
- Kara A, Turgut S, Cagli A, Sahin F, Oran E, Tunc B. Complications of therapeutic apheresis in children. Transfus Apher Sci. 2013;48:375–6.
- Erkurt ME, Kuku I, Kaya E, Ozgen U, Berber I, Koroglu M, et al. Therapeutic plasma exchange in hematologic disease: results from a single center in Eastern Anatolia. Transfus Apher Sci. 2013;48:335–9.
- Lysak D, Koristek Z, Gasova Z, Skoumalova I, Jindra P. Efficacy and safety of peripheral blood stem cell collection in elderly donors; does age interfere? J Clin Apher. 2011;26:9–16.
- Ishihara T, Inoue S, Takagi Y, Shimomura T, Sagami Y, Katayama S, et al. Adverse events in therapeutic apheresis: a single center survey of various therapies. Ther Apher Dial. 2010;14:589–95.
- Szczeklik W, Wawrzycka K, Wludarczyk A, Sega A, Nowak I, Seczynska B, et al. Complications in patients treated with plasmapheresis in the intensive care unit. Anaesthesiol Intensive Ther. 2013;45:7–13.